|
|
|
|
LEADER |
01621cas a2200349 a 4500 |
001 |
8101203 |
003 |
DNLM |
005 |
20130509061259.0 |
008 |
810219d19801989at x p 0||| 0eng |
022 |
|
|
|a 0157-7271
|l 0157-7271
|
035 |
|
|
|a (DNLM)R04990000(s)
|
035 |
|
|
|a (OCoLC)06634261
|
040 |
|
|
|a DNLM
|c DNLM
|
060 |
0 |
0 |
|a W1
|b RE1H
|
222 |
|
0 |
|a Reactions
|
245 |
0 |
0 |
|a Reactions.
|
260 |
|
|
|a [Balgowlah, N.S.W. ; New York :
|b ADIS Press,
|c c1980-1989]
|
300 |
|
|
|a v.
|
310 |
|
|
|a Fifty no. a year
|
321 |
|
|
|a Twenty two no. a year
|b 1980-1984
|
321 |
|
|
|a Bimonthly
|b 1985-1987
|
362 |
0 |
|
|a No. 1 (Jan. 25, 1980)-
|
362 |
1 |
|
|a Ceased with: No. 282, Dec. 23, 1989.
|
650 |
|
2 |
|a Drug Interactions
|v Periodicals.
|
650 |
|
2 |
|a Pharmaceutical Preparations
|x adverse effects
|v Periodicals.
|
785 |
0 |
0 |
|t Reactions weekly
|x 0114-9954
|w (OCoLC)28493176
|
999 |
|
|
|c 64684
|d 64684
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 1174019
|a MA-CBUA-UMA-FM
|b MA-CBUA-UMA-FM
|h 1990-1998(1999).
|o MA-CBUA-UMA-FM-1174019JNL-0157-7271
|p MA-CBUA-UMA-FM-1174019JNL-64684
|t 1683314
|y JNL
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 1917737
|a VI-CEVIME
|b VI-CEVIME
|h 1987-89.
|o VI-CEVIME-1917737JNL-0157-7271
|p VI-CEVIME-1917737JNL-64684
|t 2632481
|y JNL
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 1918344
|a VI-CEVIME
|b VI-CEVIME
|h 1987-89.
|o VI-CEVIME-1918344JNL-0157-7271
|p VI-CEVIME-1918344JNL-64684
|t 2632620
|y JNL
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 2155807
|a NA-DS
|b NA-DS
|h 1988-89.
|o NA-DS-2155807JNL-0157-7271
|p NA-DS-2155807JNL-64684
|t 2861417
|y JNL
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 2162495
|a AN-BV-SSPA
|b AN-BV-SSPA
|h 1981-83(1984)1985-93(1994).
|o AN-BV-SSPA-2162495JNL-0157-7271
|p AN-BV-SSPA-2162495JNL-64684
|t 2867333
|y JNL
|